The contribution of respiratory microbiome analysis to a treatable traits model of care

Steven L. Taylor, Hannah E. O'Farrell, Jodie L. Simpson, Ian A. Yang, Geraint B. Rogers

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

The composition of the airway microbiome in patients with chronic airway diseases, such as severe asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis and cystic fibrosis (CF), has the potential to inform a precision model of clinical care. Patients with these conditions share overlapping disease characteristics, including airway inflammation and airflow limitation. The clinical management of chronic respiratory conditions is increasingly moving away from a one-size-fits-all model based on primary diagnosis, towards care targeting individual disease traits, and is particularly useful for subgroups of patients who respond poorly to conventional therapies. Respiratory microbiome analysis is an important potential contributor to such a ‘treatable traits’ approach, providing insight into both microbial drivers of airways disease, and the selective characteristics of the changing lower airway environment. We explore the potential to integrate respiratory microbiome analysis into a treatable traits model of clinical care and provide a practical guide to the application and clinical interpretation of respiratory microbiome analysis.

LanguageEnglish
Pages19-28
Number of pages10
JournalRespirology
Volume24
Issue number1
DOIs
Publication statusPublished - 1 Jan 2019

Keywords

  • asthma
  • bronchiectasis
  • chronic obstructive pulmonary disease
  • cystic fibrosis
  • microbiome

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Taylor, Steven L. ; O'Farrell, Hannah E. ; Simpson, Jodie L. ; Yang, Ian A. ; Rogers, Geraint B. / The contribution of respiratory microbiome analysis to a treatable traits model of care. In: Respirology. 2019 ; Vol. 24, No. 1. pp. 19-28.
@article{129652302b264bccad4e56dc806cde5a,
title = "The contribution of respiratory microbiome analysis to a treatable traits model of care",
abstract = "The composition of the airway microbiome in patients with chronic airway diseases, such as severe asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis and cystic fibrosis (CF), has the potential to inform a precision model of clinical care. Patients with these conditions share overlapping disease characteristics, including airway inflammation and airflow limitation. The clinical management of chronic respiratory conditions is increasingly moving away from a one-size-fits-all model based on primary diagnosis, towards care targeting individual disease traits, and is particularly useful for subgroups of patients who respond poorly to conventional therapies. Respiratory microbiome analysis is an important potential contributor to such a ‘treatable traits’ approach, providing insight into both microbial drivers of airways disease, and the selective characteristics of the changing lower airway environment. We explore the potential to integrate respiratory microbiome analysis into a treatable traits model of clinical care and provide a practical guide to the application and clinical interpretation of respiratory microbiome analysis.",
keywords = "asthma, bronchiectasis, chronic obstructive pulmonary disease, cystic fibrosis, microbiome",
author = "Taylor, {Steven L.} and O'Farrell, {Hannah E.} and Simpson, {Jodie L.} and Yang, {Ian A.} and Rogers, {Geraint B.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1111/resp.13411",
language = "English",
volume = "24",
pages = "19--28",
journal = "Respirology",
issn = "1323-7799",
publisher = "Wiley-Blackwell",
number = "1",

}

The contribution of respiratory microbiome analysis to a treatable traits model of care. / Taylor, Steven L.; O'Farrell, Hannah E.; Simpson, Jodie L.; Yang, Ian A.; Rogers, Geraint B.

In: Respirology, Vol. 24, No. 1, 01.01.2019, p. 19-28.

Research output: Contribution to journalReview article

TY - JOUR

T1 - The contribution of respiratory microbiome analysis to a treatable traits model of care

AU - Taylor, Steven L.

AU - O'Farrell, Hannah E.

AU - Simpson, Jodie L.

AU - Yang, Ian A.

AU - Rogers, Geraint B.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The composition of the airway microbiome in patients with chronic airway diseases, such as severe asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis and cystic fibrosis (CF), has the potential to inform a precision model of clinical care. Patients with these conditions share overlapping disease characteristics, including airway inflammation and airflow limitation. The clinical management of chronic respiratory conditions is increasingly moving away from a one-size-fits-all model based on primary diagnosis, towards care targeting individual disease traits, and is particularly useful for subgroups of patients who respond poorly to conventional therapies. Respiratory microbiome analysis is an important potential contributor to such a ‘treatable traits’ approach, providing insight into both microbial drivers of airways disease, and the selective characteristics of the changing lower airway environment. We explore the potential to integrate respiratory microbiome analysis into a treatable traits model of clinical care and provide a practical guide to the application and clinical interpretation of respiratory microbiome analysis.

AB - The composition of the airway microbiome in patients with chronic airway diseases, such as severe asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis and cystic fibrosis (CF), has the potential to inform a precision model of clinical care. Patients with these conditions share overlapping disease characteristics, including airway inflammation and airflow limitation. The clinical management of chronic respiratory conditions is increasingly moving away from a one-size-fits-all model based on primary diagnosis, towards care targeting individual disease traits, and is particularly useful for subgroups of patients who respond poorly to conventional therapies. Respiratory microbiome analysis is an important potential contributor to such a ‘treatable traits’ approach, providing insight into both microbial drivers of airways disease, and the selective characteristics of the changing lower airway environment. We explore the potential to integrate respiratory microbiome analysis into a treatable traits model of clinical care and provide a practical guide to the application and clinical interpretation of respiratory microbiome analysis.

KW - asthma

KW - bronchiectasis

KW - chronic obstructive pulmonary disease

KW - cystic fibrosis

KW - microbiome

UR - http://www.scopus.com/inward/record.url?scp=85054404325&partnerID=8YFLogxK

U2 - 10.1111/resp.13411

DO - 10.1111/resp.13411

M3 - Review article

VL - 24

SP - 19

EP - 28

JO - Respirology

T2 - Respirology

JF - Respirology

SN - 1323-7799

IS - 1

ER -